Literature DB >> 21563177

Support of cancer patients' spiritual needs and associations with medical care costs at the end of life.

Tracy Balboni1, Michael Balboni, M Elizabeth Paulk, Andrea Phelps, Alexi Wright, John Peteet, Susan Block, Chris Lathan, Tyler Vanderweele, Holly Prigerson.   

Abstract

BACKGROUND: Although spiritual care is associated with less aggressive medical care at the end of life (EOL), it remains infrequent. It is unclear if the omission of spiritual care impacts EOL costs.
METHODS: A prospective, multisite study of 339 advanced cancer patients accrued subjects from September 2002 to August 2007 from an outpatient setting and followed them until death. Spiritual care was measured by patients' reports that the health care team supported their religious/spiritual needs. EOL costs in the last week were compared among patients reporting that their spiritual needs were inadequately supported versus those who reported that their needs were well supported. Analyses were adjusted for confounders (eg, EOL discussions).
RESULTS: Patients reporting that their religious/spiritual needs were inadequately supported by clinic staff were less likely to receive a week or more of hospice (54% vs 72.8%; P = .01) and more likely to die in an intensive care unit (ICU) (5.1% vs 1.0%, P = .03). Among minorities and high religious coping patients, those reporting poorly supported religious/spiritual needs received more ICU care (11.3% vs 1.2%, P = .03 and 13.1% vs 1.6%, P = .02, respectively), received less hospice (43.% vs 75.3% ≥1 week of hospice, P = .01 and 45.3% vs 73.1%, P = .007, respectively), and had increased ICU deaths (11.2% vs 1.2%, P = .03 and 7.7% vs 0.6%, P = .009, respectively). EOL costs were higher when patients reported that their spiritual needs were inadequately supported ($4947 vs $2833, P = .03), particularly among minorities ($6533 vs $2276, P = .02) and high religious copers ($6344 vs $2431, P = .005).
CONCLUSIONS: Cancer patients reporting that their spiritual needs are not well supported by the health care team have higher EOL costs, particularly among minorities and high religious coping patients.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21563177      PMCID: PMC3177963          DOI: 10.1002/cncr.26221

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  36 in total

1.  Palliative and end-of-life care in the African American community.

Authors:  L Crawley; R Payne; J Bolden; T Payne; P Washington; S Williams
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

2.  A case for including spirituality in quality of life measurement in oncology.

Authors:  M J Brady; A H Peterman; G Fitchett; M Mo; D Cella
Journal:  Psychooncology       Date:  1999 Sep-Oct       Impact factor: 3.894

3.  Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain.

Authors:  S R Cohen; B M Mount; E Bruera; M Provost; J Rowe; K Tong
Journal:  Palliat Med       Date:  1997-01       Impact factor: 4.762

4.  The McGill Quality of Life Questionnaire: a measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability.

Authors:  S R Cohen; B M Mount; M G Strobel; F Bui
Journal:  Palliat Med       Date:  1995-07       Impact factor: 4.762

5.  Seeking meaning and hope: self-reported spiritual and existential needs among an ethnically-diverse cancer patient population.

Authors:  A Moadel; C Morgan; A Fatone; J Grennan; J Carter; G Laruffa; A Skummy; J Dutcher
Journal:  Psychooncology       Date:  1999 Sep-Oct       Impact factor: 3.894

6.  Importance of faith on medical decisions regarding cancer care.

Authors:  Gerard A Silvestri; Sommer Knittig; James S Zoller; Paul J Nietert
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

7.  Factors considered important at the end of life by patients, family, physicians, and other care providers.

Authors:  K E Steinhauser; N A Christakis; E C Clipp; M McNeilly; L McIntyre; J A Tulsky
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

8.  Trends in the aggressiveness of cancer care near the end of life.

Authors:  Craig C Earle; Bridget A Neville; Mary Beth Landrum; John Z Ayanian; Susan D Block; Jane C Weeks
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

9.  Socialization to dying: social determinants of death acknowledgement and treatment among terminally ill geriatric patients.

Authors:  H G Prigerson
Journal:  J Health Soc Behav       Date:  1992-12

10.  Managed care, hospice use, site of death, and medical expenditures in the last year of life.

Authors:  Ezekiel J Emanuel; Arlene Ash; Wei Yu; Gail Gazelle; Norman G Levinsky; Olga Saynina; Mark McClellan; Mark Moskowitz
Journal:  Arch Intern Med       Date:  2002 Aug 12-26
View more
  64 in total

1.  Teaching health care providers to provide spiritual care: a pilot study.

Authors:  Angelika A Zollfrank; Kelly M Trevino; Wendy Cadge; Michael J Balboni; Mary Martha Thiel; George Fitchett; Kathleen Gallivan; Tyler VanderWeele; Tracy A Balboni
Journal:  J Palliat Med       Date:  2015-04-14       Impact factor: 2.947

2.  Clergy Views on a Good Versus a Poor Death: Ministry to the Terminally Ill.

Authors:  Virginia T LeBaron; Amanda Cooke; Jonathan Resmini; Alexander Garinther; Vinca Chow; Rebecca Quiñones; Sarah Noveroske; Andrew Baccari; Patrick T Smith; John Peteet; Tracy A Balboni; Michael J Balboni
Journal:  J Palliat Med       Date:  2015-08-28       Impact factor: 2.947

3.  What Impact Do Chaplains Have? A Pilot Study of Spiritual AIM for Advanced Cancer Patients in Outpatient Palliative Care.

Authors:  Allison Kestenbaum; Michele Shields; Jennifer James; Will Hocker; Stefana Morgan; Shweta Karve; Michael W Rabow; Laura B Dunn
Journal:  J Pain Symptom Manage       Date:  2017-07-21       Impact factor: 3.612

Review 4.  The role of palliative care in patients with neurological diseases.

Authors:  Gian Domenico Borasio
Journal:  Nat Rev Neurol       Date:  2013-04-02       Impact factor: 42.937

5.  Trends in End-of-Life Care in Pediatric Hematology, Oncology, and Stem Cell Transplant Patients.

Authors:  Katharine E Brock; Angela Steineck; Clare J Twist
Journal:  Pediatr Blood Cancer       Date:  2015-10-29       Impact factor: 3.167

6.  Considering religion and spirituality in precision medicine.

Authors:  Karen H K Yeary; Kassandra I Alcaraz; Kimlin Tam Ashing; Chungyi Chiu; Shannon M Christy; Katarina Friberg Felsted; Qian Lu; Crystal Y Lumpkins; Kevin S Masters; Robert L Newton; Crystal L Park; Megan J Shen; Valerie J Silfee; Betina Yanez; Jean Yi
Journal:  Transl Behav Med       Date:  2020-02-03       Impact factor: 3.046

7.  The Association of Surrogate Decision Makers' Religious and Spiritual Beliefs With End-of-Life Decisions.

Authors:  Alexia M Torke; George Fitchett; Saneta Maiko; Emily S Burke; James E Slaven; Beth Newton Watson; Steven Ivy; Patrick O Monahan
Journal:  J Pain Symptom Manage       Date:  2019-09-17       Impact factor: 3.612

8.  Quality of Life and Cost of Care at the End of Life: The Role of Advance Directives.

Authors:  Melissa M Garrido; Tracy A Balboni; Paul K Maciejewski; Yuhua Bao; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2014-12-11       Impact factor: 3.612

Review 9.  A systematic review of religious beliefs about major end-of-life issues in the five major world religions.

Authors:  Rajshekhar Chakraborty; Areej R El-Jawahri; Mark R Litzow; Karen L Syrjala; Aric D Parnes; Shahrukh K Hashmi
Journal:  Palliat Support Care       Date:  2017-10

10.  Why is spiritual care infrequent at the end of life? Spiritual care perceptions among patients, nurses, and physicians and the role of training.

Authors:  Michael J Balboni; Adam Sullivan; Adaugo Amobi; Andrea C Phelps; Daniel P Gorman; Angelika Zollfrank; John R Peteet; Holly G Prigerson; Tyler J Vanderweele; Tracy A Balboni
Journal:  J Clin Oncol       Date:  2012-12-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.